Back
Meta Platforms, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
44
META
Meta Platforms, Inc.
Last Price:
$665.09
Seasonality Move:
8.82%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.17
Seasonality Move:
11.35%
Sell
44
Meta Platforms, Inc. (META)
is a Sell
Is Meta Platforms, Inc. a Buy, Sell or Hold?
-
The current Meta Platforms, Inc. [META] share price is $649.50. The Score for META is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
META is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.31. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
META Stock Price Chart
What is Meta Platforms, Inc.'s stock price today?
-
The Meta Platforms, Inc. share price today is $649.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and META is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
META Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 50.09 | Buy |
| Chaikin Money Flow: | -14820566 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (607.43 - 658.17) | Buy |
| Bollinger Bands (100): | (649.84 - 766.58) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.9 | Buy |
| Relative Strength Index (14 RSI): | 84.85 | Buy |
| Chaikin Money Flow: | 566238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (179.97 - 241.41) | Buy |
| Bollinger Bands (100): | (53.79 - 174.17) | Buy |
META Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 653.12 | Sell |
| 20-day SMA: | 639.6 | Buy |
| 50-day SMA: | 663.76 | Sell |
| 200-day SMA: | 671.07 | Sell |
| 8-day EMA: | 651.03 | Sell |
| 20-day EMA: | 647.41 | Buy |
| 50-day EMA: | 662.88 | Sell |
| 200-day EMA: | 667.56 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.16 | Buy |
| 20-day SMA: | 220.01 | Buy |
| 50-day SMA: | 157.24 | Buy |
| 200-day SMA: | 71.79 | Buy |
| 8-day EMA: | 219.83 | Buy |
| 20-day EMA: | 208.3 | Buy |
| 50-day EMA: | 169.39 | Buy |
| 200-day EMA: | 91.98 | Buy |
Meta Platforms, Inc. Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $5.14 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Meta Platforms, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||